RLAY
Relay Therapeutics, Inc. · Healthcare
CFO Thomas Catinazzo sold $55K of Relay Therapeutics, Inc.
Sold$54,905
$6.03Price
9,102Shares
−3%Stake
What RLAY did after the filing
- The stock from Thu, Oct 31 open, $5.71
- −17.5%
- S&P 500, same days
- +5.0%
Measured over 30 trading days, to the Dec 13 close.
Traded Mon, Oct 28. Filed Wed, Oct 30, 4:09 PM ET, after the close. Returns use the Oct 31 open and the Dec 13 close. Not investment advice.